ARCHIVES

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

This article is from The Cancer Letter archive.

Vol. 26 No. 36 | October 6, 2000

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000